Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs aspirin for embolic stroke of undetermined source
CTR20150785Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in embolic stroke of undetermined source (ESUS), sponsored by Bayer. Started Jan 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
embolic stroke of undetermined source (ESUS)
Beyond the preview
Go deeper on CTR20150785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150785.